Advertisement

Topics

Tibotec Pharmaceuticals Company Profile

19:43 EDT 29th June 2016 | BioPortfolio

Tibotec Pharmaceuticals, based in Cork, Ireland, is a pharmaceutical research and development company. The Company's main research and development facilities are in Mechelen, Belgium with offices in Yardley, PA. Tibotec is dedicated to the discovery and development of innovative HIV/AIDS drugs and anti-infectives for diseases of high unmet medical need.


News Articles [970 Associated News Articles listed on BioPortfolio]

Jazz Pharmaceuticals Acquires Celator for $1.5B

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) and Celator Pharmaceuticals, Inc. (Nasdaq: CPXX) today announced that they have entered into a definitive agreement for Jazz Pharmaceuticals to acquire Celator ...

Titan Pharmaceuticals And Braeburn Pharmaceuticals Announce FDA Advisory Committee Recommends Approval Of Probuphine

SOUTH SAN FRANCISCO, CA and PRINCETON, NJ – January 12, 2016 –Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) and partner Braeburn Pharmaceuticals today announced that the Psychopharmacologic Drugs Advi...

Jazz Pharmaceuticals to Acquire Celator

NewsJazz Pharmaceuticals and Celator Pharmaceuticals announce agreement for Jazz Pharmaceuticals to acquire Celator for $30.25 per share.

Jazz Pharmaceuticals And Celator Pharmaceuticals Announce Agreement For Jazz Pharmaceuticals To ...

1Included secondary AML and de novo AML with a karyotype characteristic of myelodysplastic syndrome (MDS) 2 U.S. FDA Breakthrough Therapy designat...

Novartis splits pharmaceuticals division into two business units

Novartis has announced internal structural changes that it says will “focus” its pharmaceuticals division by creating two business units, Novartis Pharmaceuticals and Novartis Oncology, reporting ...

M&As this week: Savara Pharma, Xiangxue Pharmaceuticals

Savara Pharmaceuticals plans to expand its pipeline of orphan respiratory drugs by acquiring Serendex Pharmaceuticals, a provider of inhalation therapies for rare respiratory conditions.

Ampio Pharma spins off Vyrix Pharmaceuticals

Ampio Pharmaceuticals Inc. (drugs for inflammatory conditions) spun off its sexual dysfunction business into Vyrix Pharmaceuticals Inc.

How does biotechnology reconcile ties to big bad pharmaceuticals industry?

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis. As the CEO of the Cambridge-based drug company Ironwood Pharmaceuticals, Peter Hecht sees the...

Drugs and Medications [0 Results]

None

PubMed Articles [143 Associated PubMed Articles listed on BioPortfolio]

Biotransformation of pharmaceuticals by ammonia oxidizing bacteria in wastewater treatment processes.

Pharmaceutical residues could potentially pose detrimental effects on aquatic ecosystems and human health, with wastewater treatment being one of the major pathways for pharmaceuticals to enter into t...

Removal of pharmaceuticals from secondary effluents by an electro-peroxone process.

This study compared the removal of pharmaceuticals from secondary effluents of wastewater treatment plants (WWTPs) by conventional ozonation and the electro-peroxone (E-peroxone) process, which involv...

Ranking Prescribed Pharmaceuticals in Terms of Environmental Risk: Inclusion of Hospital Data and the Importance of Regular Review.

A newly available dataset on pharmaceuticals used in Scottish hospitals enabled an Environmental Risk Assessment that includes hospital consumption of pharmaceuticals, as previous UK rankings have bee...

Uptake, depuration, and bioconcentration of two pharmaceuticals, roxithromycin and propranolol, in Daphnia magna.

The objective of the present study was to investigate the uptake, depuration, and bioconcentration of two pharmaceuticals, roxithromycin (ROX) and propranolol (PRP), in Daphnia magna via aqueous expos...

Acute toxicities of pharmaceuticals toward green algae. mode of action, biopharmaceutical drug disposition classification system and quantile regression models.

The acute toxicities of 36 pharmaceuticals towards green algae were estimated from a set of quantile regression models representing the first global quantitative structure-activity relationships. The ...

Clinical Trials [6 Associated Clinical Trials listed on BioPortfolio]

TMC114-TiDP29-C232 - Study Providing Continued Access to Treatment With Darunavir (DRV)/Ritonavir (Rtv) for Children Coming From Any of the Three Ongoing Tibotec Sponsored Pediatric Studies With DRV

The primary objective of this study is to continue to provide Darunavir (DRV) to pediatric patients who previously received DRV in any of three pediatric clinical studies sponsored by Tibo...

TMC114-C209: A Study of Safety of TMC114 With Low Dose Ritonavir (RTV) and Other Antiretrovirals in Experienced HIV-1 Infected Patients With Limited or no Treatment Options

This is an open-label safety study to provide early access to TMC114 for HIV-1 infected patients who have failed and exhausted regimens based on commercially available antiretroviral (ARV)...

TMC125-TiDP35-C239 - Continued Access to Etravirine (ETR) in Treatment Experienced HIV-1 Infected Children and Adolescents

The primary objective is to continue the provision of etravirine (ETR) for patients who previously received ETR in a clinical pediatric trial sponsored by or in collaboration with Tibotec,...

Study of Equivalence of Generic Pimecrolimus Cream 1% and Elidel® 1% in Subjects With Mild to Moderate Atopic Dermatitis

The purpose of this study is to compare the safety and efficacy profiles of Watson Laboratories, Inc.'s Pimecrolimus Cream, 1% to those of Valeant Pharmaceuticals North America LLC's Elide...

TOL-463 Phase 2 Study

This is a Phase II randomized single blind (investigator-blinded) safety and efficacy study in approximately 90 adult females 18-50 years of age (to achieve 80 evaluable participants) at t...

Companies [10 Associated Companies listed on BioPortfolio]

Tibotec, Inc

Tibotec is a pharmaceutical research and development company dedicated to the discovery and development of innovative new drugs for HIV/AIDS and other infectious diseases of high unmet medical need. T...

Tibotec Pharmaceuticals Ltd.

Tibotec Pharmaceuticals Ltd., based in Cork, Ireland, is a pharmaceutical research and development company. The Company's main research and development facilities are in Mechelen, Belgium with off...

Tibotec Inc.

Tibotec Inc., based in Yardley, Pa., USA, is a pharmaceutical research and development company. The Company's main research and development facilities are in Mechelen, Belgium with offices in Cork, Ir...

Tibotec Pharmaceuticals

Tibotec Pharmaceuticals, based in Cork, Ireland, is a pharmaceutical research and development company. The Company's main research and development facilities are in Mechelen, Belgium with offices in Y...

Tibotec Therapeutics

More Information about "Tibotec Pharmaceuticals" on BioPortfolio

We have published hundreds of Tibotec Pharmaceuticals news stories on BioPortfolio along with dozens of Tibotec Pharmaceuticals Clinical Trials and PubMed Articles about Tibotec Pharmaceuticals for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Tibotec Pharmaceuticals Companies in our database. You can also find out about relevant Tibotec Pharmaceuticals Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record